- 18 Sep 2020 7:23 AM
- Hungary Matters
The company will expand production capacity at the base in northern Hungary by almost 50%, Szijjártó said.
The new production line will have capacity to make up to 90,000 syringes per hour, he added.
Protection efforts against the coronavirus pandemic have further increased the sector’s value, he said.
Sanofi Hungary CEO Tamás Rónay said the company had invested 24 billion forints at the plant over the past three decades, demonstrating its long-term commitment to Hungary.
MTI Photo: Noémi Bruzák